PL
RPRX icon

Perpetual Ltd’s Royalty Pharma RPRX Stock Holding History

Perpetual Ltd’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499K Sell
8,900
-60
-0.7% -$3.12K 0.01% 327
2026
Q1 		$430K Hold
8,960
– – 0.01% 340
2025
Q4 		$346K Buy
+8,960
New +$342K 0.01% 356

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Perpetual Ltd's RPRX Position: Q2 2026 in Review

Perpetual Ltd reduced its Royalty Pharma (RPRX) stake by 0.67% in Q2 2026, selling an estimated $3.12K and leaving 8,900 shares worth $499K. The position accounts for 0.01% of the portfolio, ranked #327.

Perpetual Ltd first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. 153 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Perpetual Ltd held 8,900 shares of Royalty Pharma worth $499K as of Q2 2026.
  • Perpetual Ltd sold 60 Royalty Pharma shares in Q2 2026, an estimated $3.12K.
  • Royalty Pharma made up 0.01% of Perpetual Ltd's portfolio in Q2 2026, its #327 holding.
  • Perpetual Ltd first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • 153 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.